FDA delays decision on first drug to prevent HIV infection

   Jun 9, 4:37 pm

London, June 9 (ANI): US health regulators have delayed until mid-September a decision on whether to approve Truvada as the first pill that prevents HIV infection.

Drug maker Gilead Sciences said on Friday that the Food and Drug Administration (FDA) would take an additional three months to review its drug application, after the California Company submitted additional materials to the agency earlier this month.

In May, a panel of experts recommended approval of the daily pill for healthy people at high risk of contracting HIV, the Daily Express reported.

The group's vote is non-binding, but the FDA often follows its advice.

Gilead said that it had submitted updated details on its safety materials for patients and doctors using Truvada.

The FDA typically extends its reviews after receiving such information. (ANI)

Viagra use can lead to vision disturbances in some Oct 1, 1:25 pm
Washington, Oct 1 (ANI): A new research has revealed that erectile dysfunction drugs can affect vision of genetically susceptible users.
Full Story
New test pinpoints people susceptible to stress Oct 1, 1:09 pm
Washington, Oct 1 (ANI): Scientists have revealed that they have found a way to identify those most susceptible to stress, which can prove to be a huge help for healthcare professionals.
Full Story
Smoking ganja at early age hits immune system in adulthood Oct 1, 12:56 pm
Washington, Oct 1 (ANI): A new research has revealed that smoking marijuana during adolescence can lead to immune-related diseases in adulthood.
Full Story
Premature births, pneumonia biggest causes of death in kids under 5 years Oct 1, 10:28 am
London, Oct 1 (ANI): A new study has revealed that preterm birth complications and pneumonia are the leading causes of death in children who are under 5 years and are together responsible for nearly 2 million deaths in 2013.
Full Story
Comments

LATEST STORIES
TOP VIDEO STORIES
PHOTO GALLERY